Les Funtleyder, health care strategist of Miller Tabak, told CNBC that investors can benefit from certain health care companies that will be boosted by the stimulus package.
UPDATE: THE TRIPLE TOP WAS JUST TOO DIFFICULT FOR ILMN TO BREAKTHROUGH. OUR ORIGINAL SHORT TERM PROFIT THESIS HAS BEEN VIOLATED. LET'S SELL FOR A 2% LOSS AND LOOK FOR PROFITS ELSEWHERE.
“We’re just looking at fundamentals rather than macro,” he told CNBC. “We’re looking specifically at the genetic analysis space like the Illuminas and Luminexes of the world.”
My latest pick and a stock I bought on Friday, May 2, 2009 is Illumina.
In the video below I explain my reasoning and how a triple top breakout play could make us a lot of money in this stock.
Les Funtleyder, health care strategist of Miller Tabak, told CNBC that investors can benefit from certain health care companies that will be boosted by the stimulus package.
UPDATE: THE TRIPLE TOP WAS JUST TOO DIFFICULT FOR ILMN TO BREAKTHROUGH. OUR ORIGINAL SHORT TERM PROFIT THESIS HAS BEEN VIOLATED. LET'S SELL FOR A 2% LOSS AND LOOK FOR PROFITS ELSEWHERE.
“We’re just looking at fundamentals rather than macro,” he told CNBC. “We’re looking specifically at the genetic analysis space like the Illuminas and Luminexes of the world.”
My latest pick and a stock I bought on Friday, May 2, 2009 is Illumina.
In the video below I explain my reasoning and how a triple top breakout play could make us a lot of money in this stock.
Les Funtleyder, health care strategist of Miller Tabak, told CNBC that investors can benefit from certain health care companies that will be boosted by the stimulus package.
UPDATE: THE TRIPLE TOP WAS JUST TOO DIFFICULT FOR ILMN TO BREAKTHROUGH. OUR ORIGINAL SHORT TERM PROFIT THESIS HAS BEEN VIOLATED. LET'S SELL FOR A 2% LOSS AND LOOK FOR PROFITS ELSEWHERE.
“We’re just looking at fundamentals rather than macro,” he told CNBC. “We’re looking specifically at the genetic analysis space like the Illuminas and Luminexes of the world.”
My latest pick and a stock I bought on Friday, May 2, 2009 is Illumina.
In the video below I explain my reasoning and how a triple top breakout play could make us a lot of money in this stock.
Copyright 2009-2011 GuerillaStockTrading.com All rights reserved. No part or article on this website may be copied or duplicated without written consent from GuerillaStockTrading.com and Confab Publishing. Disclaimer: This Web site is designed to provide accurate and authoritative information on the subject of personal finances. It is provided with the understanding that neither the author nor the publisher is engaged in rendering legal, accounting, or other professional services by providing this Web site. The authors and publisher shall not be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential or other damages. As each individual situation is unique, questions relevant to personal finances and specific to the individual should be addressed to an appropriate professional to ensure that the situation has been carefully and appropriately evaluated. This blog is for information and entertainment purposes only. Under no circumstances does this information represent a recommendation to buy or sell securities or any other type of investment instruments. See a licensed broker for investment advice.
Guerilla Stock Trading University